Xspray Pharma publishes prospectus in connection with its listing on Nasdaq Stockholm
STOCKHOLM – March 23, 2020. Xspray Pharma AB (Nasdaq First North Growth Market: XSPRAY) announced on March 18, 2020 that Nasdaq Stockholm’s listing committee had approved that the company’s shares are admitted to trading on Nasdaq Stockholm’s main market. Today, on 23 March, the prospectus that has been prepared by the company in connection with the listing was approved and registered by the Swedish Financial Supervisory Authority (“SFSA”) and is now available on Xspray Pharma’s website, www.xspraypharma.com, and on SFSA’s website, www.fi.se.The first day of trading on Nasdaq Stockholm’s